Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to $18000.0.

  • Champions Oncology's Tax Provisions rose 6363.64% to $18000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$74000.0, marking a year-over-year decrease of 9473.68%. This contributed to the annual value of -$75000.0 for FY2025, which is 13437.5% down from last year.
  • According to the latest figures from Q4 2025, Champions Oncology's Tax Provisions is $18000.0, which was up 6363.64% from $14000.0 recorded in Q3 2025.
  • Champions Oncology's Tax Provisions' 5-year high stood at $32000.0 during Q2 2021, with a 5-year trough of -$129000.0 in Q2 2025.
  • Moreover, its 5-year median value for Tax Provisions was $14000.0 (2021), whereas its average is $3850.0.
  • In the last 5 years, Champions Oncology's Tax Provisions skyrocketed by 110000.0% in 2023 and then tumbled by 50500.0% in 2024.
  • Quarter analysis of 5 years shows Champions Oncology's Tax Provisions stood at $12000.0 in 2021, then grew by 16.67% to $14000.0 in 2022, then fell by 21.43% to $11000.0 in 2023, then changed by 0.0% to $11000.0 in 2024, then skyrocketed by 63.64% to $18000.0 in 2025.
  • Its Tax Provisions was $18000.0 in Q4 2025, compared to $14000.0 in Q3 2025 and -$129000.0 in Q2 2025.